Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 96 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Vassiliki Kotoula  [Clear All Filters]
2014
Krikelis, D., Kotoula V., Bobos M., Fountzilas E., Markou K., Karasmanis I., et al. (2014).  Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.. Anticancer Res. 34(11), 6495-503.
Pentheroudakis, G., Kotoula V., Fountzilas E., Kouvatseas G., Basdanis G., Xanthakis I., et al. (2014).  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).. BMC Cancer. 14, 111.
Koutras, A. K., Kotoula V., Papadimitriou C., Dionysopoulos D., Zagouri F., Kalofonos H. P., et al. (2014).  Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.. Pharmacogenomics J. 14(3), 248-55.
2013
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Fountzilas, E., Kotoula V., Angouridakis N., Karasmanis I., Wirtz R. M., Eleftheraki A. G., et al. (2013).  Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.. PLoS One. 8(8), e70429.
Mountzios, G., Kostopoulos I., Kotoula V., Sfakianaki I., Fountzilas E., Markou K., et al. (2013).  Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.. PLoS One. 8(1), e54048.
Fountzilas, G., Kotoula V., Pectasides D., Kouvatseas G., Timotheadou E., Bobos M., et al. (2013).  Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.. PLoS One. 8(7), e69256.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.
Pentheroudakis, G., Kotoula V., Eleftheraki A. G., Tsolaki E., Wirtz R. M., Kalogeras K. T., et al. (2013).  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).. PLoS One. 8(7), e70634.
Kamposioras, K., Konstantara A., Kotoula V., Lakis S., Kouvatseas G., Akriviadis E., et al. (2013).  The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.. Anticancer Res. 33(10), 4573-84.
Koletsa, T., Kotoula V., Christoforidou A., Pantelidou P., Petrakis G., Tsatalas C., et al. (2013).  An unusual case of biphenotypic, bigenotypic mature lymphoma.. J Clin Pathol. 66(12), 1090-2.
2012
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Kotoula, V., Krikelis D., Karavasilis V., Koletsa T., Eleftheraki A. G., Televantou D., et al. (2012).  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).. BMC Cancer. 12, 342.
Fountzilas, G., Valavanis C., Kotoula V., Eleftheraki A. G., Kalogeras K. T., Tzaida O., et al. (2012).  HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.. J Transl Med. 10, 10.
Masoura, S., Kourtis A., Kalogiannidis I., Kotoula V., Anagnostou E., Angelidou S., et al. (2012).  Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a 23-year-old woman: A case report.. Pathol Res Pract. 208(4), 245-9.
Pentheroudakis, G., Nicolaou I., Kotoula V., Fountzilas E., Markou K., Eleftheraki A. G., et al. (2012).  Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.. Oral Oncol. 48(8), 709-16.
Pazaitou-Panayiotou, K., Janson E. Tiensuu, Koletsa T., Kotoula V., Stridsberg M., Karkavelas G., et al. (2012).  Somatostatin receptor expression in non-medullary thyroid carcinomas.. Hormones (Athens). 11(3), 290-6.
Papakonstantinou, E., Klagas I., Karakiulakis G., Hostettler K., S'ng C. Teck, Kotoula V., et al. (2012).  Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells.. Am J Respir Cell Mol Biol. 47(6), 759-67.
Iliadis, G., Kotoula V., Chatzisotiriou A., Televantou D., Eleftheraki A. G., Lambaki S., et al. (2012).  Volumetric and MGMT parameters in glioblastoma patients: survival analysis.. BMC Cancer. 12, 3.
2011
Katafigiotis, S., Papamichos S. I., Katopodi R., Papazisis K., Mylonaki E., Repana D., et al. (2011).  A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state.. Eur J Cancer Prev. 20(3), 248-51.
Mitsiades, N., Chew S. Anne, He B., Riechardt A. I., Karadedou T., Kotoula V., et al. (2011).  Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.. Invest Ophthalmol Vis Sci. 52(10), 7248-55.
Fountzilas, G., Kourea H. P., Bobos M., Televantou D., Kotoula V., Papadimitriou C., et al. (2011).  Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.. Anticancer Res. 31(9), 3007-18.
Papamichos, S. I., Lambropoulos A. F., & Kotoula V. (2011).  Putative EMT induction by OCT4Bs' shutdown.. Biochem Biophys Res Commun. 415(2), 426-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές